Maternal plasma transforming growth factor-β₁ concentrations in preeclamptic and normotensive pregnant Zimbabwean women

References

• Benian A, Madazli R, Aksu F, et al. Plasma and placental levels of interleukin-10, transforming growth factor-fl, and epithelial-cadherin in preeclampsia. Obstet Gynecol 2002;100:327–331.
   PubMed Web of Science ®Google Scholar
• Huber A, Hefler L., Tempfer C, et al. Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2002;81:168–171.
   PubMed Web of Science ®Google Scholar
• Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133–146.
   PubMed Web of Science ®Google Scholar
• Bitzer M, Sterzel RB, Bottinger EP. Transforming growth factor-fl in renal disease. Kidney Blood Press Res 1998;21:1–12.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180: 499–506.
   Google Scholar
• Raghupathy R, Tangri S. Immunodystrophism, T cells, cytokines, and pregnancy failure. Am J Reprod Immunol 1996;35:291–296.
   PubMed Web of Science ®Google Scholar
• Floridon C, Nielsen 0, Holund B, et al. Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy. Mol Hum Reprod 2000;6:943–950.
   Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499–506.
   Google Scholar
• Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80–86.
   PubMed Web of Science ®Google Scholar
• Muy-Rivera M, Sanchez SE, Vadachkoria S, et al. Transform-ing growth factor-betal (TGF-fii) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflam-mation. Am J Hypertens 2004;17:334–338.
   Google Scholar
• Djurovic S, Schjetlein R, Wisloff F, et al. Plasma concentra-tions of Lp(a) lipoprotein and TGF-B1 are altered in preeclampsia. Chin Genet 1997;52:371–376.
   Web of Science ®Google Scholar
• Wilczynski Jr, Tchorzewski H, Banasik M, et al. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol 2003;109:8–15.
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Mottonen M, Pulkki K, et al. Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia. Scand J Immunol 2001;53:310–314.
   PubMed Web of Science ®Google Scholar
• Hennessy A, Orange S, Willis NO, et al. Transforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia. Chin Exp Pharmacol Physiol 2002;29:968–971.
   PubMed Web of Science ®Google Scholar
• Williams MA, Woelk GB, King IB, et al. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women. Am J Hypertens 2003;16:665–672.
   PubMed Web of Science ®Google Scholar
• Williams MA, Mohamed K, Farrand A, et al. Plasma tumor necrosis factor-alpha soluble receptor p55 (5TNFp55) con-centrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women. J Reprod Immunol 1998;40:159–173.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Hy-pertension in pregnancy. ACOG Technical Bulletin 1996;219:1–8.
   Google Scholar
• Seelig M. Review and hypothesis: Might patients with the Chronic Fatigue Syndrome have latent tetany of magnesium deficiency. J Chronic Fatigue Syndrome 1998;4(2):77–108.
   Google Scholar
• Grainger DJ, Frow EK. Thrombospondin 1 does not activate transforming growth factor B1 in a chemically defined system or in smooth-muscle-cell culture. Biochem J 2000;350:291–298.
   PubMed Web of Science ®Google Scholar
• Clausen T, Djurovic S, Reseland JE, et al. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta 2002;23:380–385.
   Google Scholar
• Naicker T, Khedun SM, Moodley J. Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia. J Obstet Gynaecol 2002;22: 279–282.
   Google Scholar
• Clark DA, Coker R. Transforming growth factor-B. Int J Biochem Cell Biol 1998;30:293–298.
   PubMed Web of Science ®Google Scholar
• Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770–774.
   PubMed Web of Science ®Google Scholar
• Border WA, Ruoslahti E. Transforming growth factor -B in disease: the dark side of tissue repair. J Chin Invest 1993;90:1–7.
   Web of Science ®Google Scholar
• Grainger DJ, Metcalfe J. A pivotal role for TGF-B in atherogenesis? Biol Rev Camb Phil Soc 1995;70:571–596.
   PubMed Web of Science ®Google Scholar
• Reiss M. Transforming growth factor-beta and cancer: a love-hate relationship? Oncol Res 1997;9:447–457.
   PubMed Web of Science ®Google Scholar
• Prud'homme GJ, Piccirillo C. The inhibitory effects of transforming growth factor-fij (TGF-#1) in autoimmune diseases. J Autoimmun 2000;14:23–42.
   PubMedGoogle Scholar